Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2006

Apr 26, 2006

29777_dirs_2006-04-26_69b9216e-a3d2-4765-88cd-ee451c4c9108.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-04-24

Reporting Person: Chen Thomas F (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-04-24 Common shares without par value A 14000 $41.48 Acquired 71140 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-04-24 Option (right to buy) $41.48 A 47000 Acquired 2016-04-23 common shares (47000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 16708 Indirect
Common shares without par value 23798 Indirect
Common shares without par value 2476 Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 25, 2006.

F3: Reporting person disclaims beneficial ownership of all securities held by his wife and daughter.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 15,667 on 4/24/07, 15,667 on 4/24/08 and 15,666 on 4/24/09.